What medications can be used to treat cocaine use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Treating Cocaine Use Disorder

Currently, there are no FDA-approved medications specifically for cocaine use disorder, but contingency management plus community reinforcement approach is the most effective treatment combination for improving morbidity, mortality, and quality of life outcomes. 1

Psychosocial Interventions (First-Line Treatment)

  • Contingency Management (CM) plus Community Reinforcement Approach (CRA) is the most effective treatment combination, with only 4 patients needing treatment to have 1 additional patient achieve abstinence compared to treatment as usual 2, 1
  • Contingency Management (CM) alone or combined with Cognitive Behavioral Therapy (CBT) shows superior efficacy compared to treatment as usual 2, 1
  • CBT alone is recommended as an alternative when CM+CRA is not available, though it shows less efficacy 1

Pharmacological Options (Adjunctive Treatments)

Medications with Some Evidence of Efficacy:

  • Psychostimulants: May improve cocaine abstinence (RR 1.36,95% CI 1.05 to 1.77) though evidence quality is very low 3

    • Dexamphetamine and lisdexamfetamine show promise for reducing cocaine use 3
    • Particularly effective in patients with co-occurring opioid use disorder on methadone maintenance 3
  • Bupropion: May increase abstinence rates (RR 1.63,95% CI 1.02 to 2.59) with low strength of evidence 4

    • However, some studies show no significant difference between bupropion and placebo when combined with CBT 5
  • Topiramate: May improve abstinence (RR 2.56,95% CI 1.39 to 4.73) with low strength of evidence 4

  • Varenicline: Shows potential for decreasing cocaine use and reward in preliminary studies 6

Medications for Specific Symptoms:

  • For cocaine craving: Clonidine, mirtazapine, and progesterone have shown some promise in reducing cravings 7

  • For co-occurring mental health conditions: Antipsychotics may improve treatment retention (RR 1.33,95% CI 1.03 to 1.75) with moderate strength of evidence 4

Management of Acute Cocaine-Related Complications

  • For cocaine-associated chest pain:
    • Benzodiazepines are first-line treatment 2
    • Nitroglycerin can relieve cocaine-associated chest pain and reverse cocaine-associated vasoconstriction 2
    • Avoid beta-blockers as they can worsen coronary vasoconstriction 2, 1
    • Calcium channel blockers should not be used as first-line treatment but may be considered for patients who don't respond to benzodiazepines and nitroglycerin 2

Comprehensive Treatment Approach

  • Integrate substance use disorder screening into routine care, particularly for high-risk populations 1, 8
  • Assess for medical complications of stimulant use, particularly cardiovascular issues 1
  • Provide harm reduction services including naloxone dispensation, safe use education, and referral to syringe services 1, 8
  • For patients with co-occurring opioid and stimulant use disorders, medications for opioid use disorder should be initiated without delay 1

Common Pitfalls to Avoid

  • Relying solely on drug testing without clinical context can lead to misdiagnosis 1
  • Using selective β1-blockers in patients who may continue to use cocaine can lead to unopposed α-adrenergic stimulation 1
  • Failing to recognize that stimulant use disorders frequently co-occur with other substance use and mental health disorders 1, 8
  • Focusing solely on abstinence rather than harm reduction approaches 8

References

Guideline

Guidelines for Screening and Treatment of Stimulant Use Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Psychostimulant drugs for cocaine dependence.

The Cochrane database of systematic reviews, 2016

Guideline

Medical Treatment for Substance Use Disorder (SUD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.